Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shi

Showing results (441-450 of 546) with videos related to

Pageof 55
Sort By:
Circulation|September 13, 2019
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HFSenthil Selvaraj, Brian Claggett, Andrea Pozzi, et al.
Science (New York, N.Y.)|April 13, 2019
Deubiquitinase USP10 regulates Notch signaling in the endotheliumR Lim, T Sugino, H Nolte, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 8, 2021
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERELi Shen, Brian L Claggett, Pardeep S Jhund, et al.
European Heart Journal|August 2, 2015
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HFPardeep S Jhund, Michael Fu, Edmundo Bayram, et al.
European Journal of Heart Failure|November 17, 2022
Health-related quality of life outcomes in PARAGON-HFAlvin Chandra, Carisi A Polanczyk, Brian L Claggett, et al.
European Journal of Heart Failure|December 2, 2017
Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HFUlrik M Mogensen, Lars Køber, Pardeep S Jhund, et al.
Bone Marrow Transplantation|January 10, 2017
Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial resultsZ Liu, Y Zhang, H Xiao, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|August 28, 2020
Clinical and radiological characteristics of COVID-19: a multicentre, retrospective, observational studyY Wang, S Luo, C S Zhou, et al.
Bone Marrow Transplantation|July 6, 2017
Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial resultsZ Liu, Y Zhang, H Xiao, et al.
Journal of the American College of Cardiology|August 1, 2020
Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEFJonathan W Cunningham, Brian L Claggett, Eileen O'Meara, et al.
Pageof 55

Showing results (441-450 of 546) with videos related to

Sort By:
Pageof 55
Circulation|September 13, 2019
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HFSenthil Selvaraj, Brian Claggett, Andrea Pozzi, et al.
Science (New York, N.Y.)|April 13, 2019
Deubiquitinase USP10 regulates Notch signaling in the endotheliumR Lim, T Sugino, H Nolte, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 8, 2021
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERELi Shen, Brian L Claggett, Pardeep S Jhund, et al.
European Heart Journal|August 2, 2015
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HFPardeep S Jhund, Michael Fu, Edmundo Bayram, et al.
European Journal of Heart Failure|November 17, 2022
Health-related quality of life outcomes in PARAGON-HFAlvin Chandra, Carisi A Polanczyk, Brian L Claggett, et al.
European Journal of Heart Failure|December 2, 2017
Sacubitril/valsartan reduces serum uric acid concentration, an independent predictor of adverse outcomes in PARADIGM-HFUlrik M Mogensen, Lars Køber, Pardeep S Jhund, et al.
Bone Marrow Transplantation|January 10, 2017
Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial resultsZ Liu, Y Zhang, H Xiao, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|August 28, 2020
Clinical and radiological characteristics of COVID-19: a multicentre, retrospective, observational studyY Wang, S Luo, C S Zhou, et al.
Bone Marrow Transplantation|July 6, 2017
Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial resultsZ Liu, Y Zhang, H Xiao, et al.
Journal of the American College of Cardiology|August 1, 2020
Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEFJonathan W Cunningham, Brian L Claggett, Eileen O'Meara, et al.
Pageof 55